What You Ought to Know:
– LabConnect, a world supplier of central laboratory companies, has introduced a strategic collaboration with OmniScience, the AI firm behind the Vivo platform.
– Collectively, the businesses will ship an AI Agentic resolution to provide sponsors clever, real-time insights from medical trial lab information.
Reworking Lab Knowledge into Actual-Time Motion
Medical trial lab information is usually advanced, siloed, and delayed, which might result in gradual decision-making and elevated danger. By combining LabConnect’s experience in central lab testing with OmniScience’s Vivo platform, trial sponsors can now unify fragmented lab datasets, automate oversight, and floor danger indicators. This collaboration goals to speed up trial timelines and enhance outcomes.
Vivo is an AI-native medical trial intelligence platform that unifies disparate information sources to offer real-time insights. The platform features as a “management tower” to equip medical, operational, security, and information science groups with the readability they should act sooner and extra confidently.
Vivo-Lab, a specialised implementation of Vivo, brings this identical intelligence to laboratory information. It streamlines lab workflows by surfacing essential tendencies, anomalies, and site-level discrepancies as they occur, serving to groups transfer from reactive to proactive oversight.
“Our mission at OmniScience is to assist trial groups see and act sooner,” mentioned Angela Holmes, CEO and Co-Founding father of OmniScience. “Partnering with LabConnect extends that imaginative and prescient by remodeling lab information into actual time actionable intelligence that sponsors can belief”.
